Unidirectional valved patch closure of ventricular septal defects with severe pulmonary arterial hypertension

Sachin Talwar1, Shiv Kumar Choudhary, Sanket Garg

  • 1Cardiothoracic Centre, All India Institute of Medical Sciences, New Delhi, India. sachintalwar@hotmail.com

Insights

Unidirectional valved patch (UVP) closure effectively treats large ventricular septal defects (VSD) with severe pulmonary arterial hypertension (PAH). This technique offers a promising solution, reducing complications and improving patient outcomes in developing countries.

Area of Science:

  • Cardiology
  • Pediatric Surgery
  • Pulmonary Hypertension

Background:

  • Delayed presentation of large ventricular septal defects (VSD) is prevalent in developing nations.
  • Patients with VSD often develop severe pulmonary arterial hypertension (PAH), leading to increased surgical risks.

Purpose of the Study:

  • To evaluate the efficacy of a unidirectional valved patch (UVP) technique for VSD closure in patients with severe PAH.
  • To assess the safety and outcomes of UVP closure in this high-risk population.

Main Methods:

  • Seventeen patients (age 2-23 years) with large VSD and severe PAH underwent VSD closure using the UVP technique between 2006 and 2010.
  • Pre-operative assessments included pulmonary vascular resistance (PVRI) and systemic oxygen saturation.
  • Intra-operative and post-operative echocardiography monitored shunt status and recovery.

Main Results:

  • No in-hospital deaths occurred, and all patients experienced uneventful recovery.
  • Post-operative follow-up (mean 30 months) showed no shunt across the patch and systemic saturation >95% in all patients.
  • Three younger patients (2, 7, 9 years) with high pre-operative PVRI showed transient right-to-left shunting intra-operatively, which resolved.

Conclusions:

  • Unidirectional valved patch (UVP) closure is a safe and effective technique for managing large VSDs with severe PAH.
  • UVP offers a promising surgical option for patients in developing countries facing delayed VSD presentation and associated complications.